Kalogon Unveils Verro: A New Era of Hyper-Personalized Wheelchair Cushions Powered by 3D Printing for Complex Seating Needs

Melbourne, FL – [Insert Date of Publication, e.g., July 20, 2026] – Kalogon, a leading innovator in smart seating solutions, today announced a significant expansion of its product line with the launch of Verro, a groundbreaking series of Medicare-coded custom wheelchair cushions. Designed to address the nuanced and often challenging postural support requirements of individuals with complex seating needs, Verro introduces a revolutionary approach combining advanced 3D-printed variable-density lattice technology with sophisticated dual-density foam options. This launch marks a pivotal moment in the complex rehab technology (CRT) market, promising unparalleled precision, comfort, and support for wheelchair users who have historically struggled to find adequately customized solutions.

The Verro line, available in two distinct models – the Verro variable-density lattice (Verro Lattice) and the Verro dual-density foam (Verro Foam) – is engineered to provide a precise, body-conforming fit that standard, off-the-shelf cushions simply cannot deliver. This includes individuals presenting with conditions such as windswept posture, pelvic obliquity, or significant asymmetry, where even slight variations in support can dramatically impact stability, pressure redistribution, and overall well-being. By leveraging cutting-edge manufacturing processes and a deep understanding of biomechanics, Kalogon aims to bridge a critical gap in personalized rehabilitation equipment, enhancing both the functional independence and quality of life for a broad spectrum of users.

Main Facts: Redefining Custom Seating with Precision and Innovation

Kalogon’s Verro custom wheelchair cushion line represents a significant leap forward in the field of assistive technology. At its core, Verro is about hyper-personalization, moving beyond generalized support to offer truly individualized solutions for the most challenging seating cases.

The flagship offering, the Verro Lattice, integrates Kalogon’s patent-pending variable-density lattice technology. This innovation utilizes a 3D-printed elastomer construction that allows for precise control over the firmness of the cushion surface. Strategically, the material is firmer in areas where the body requires robust support to maintain proper alignment and posture, while it is softer in regions where pressure needs to be diffused to prevent skin breakdown and enhance comfort. This dynamic distribution of firmness is a game-changer, enabling a level of contouring and support previously unattainable with traditional manufacturing methods. Beyond its structural benefits, the lattice design inherently promotes superior breathability and temperature regulation, addressing common issues of heat and moisture buildup that can compromise skin integrity for long-term wheelchair users.

Complementing the advanced lattice model, the Verro Foam offers a dual-density foam construction. This option features a dense foam base for foundational support and stability, topped with a softer foam layer for enhanced comfort and pressure relief. While perhaps less technologically intricate than its lattice counterpart, Verro Foam is designed for clinicians and users who prioritize adaptability after initial fitting, or for those transitioning to contoured seating who might prefer a more familiar material feel. Both Verro models are designed to meet the rigorous demands of daily use, ensuring durability and consistent performance.

A crucial aspect of the Verro launch is its Medicare coding (E2609). This designation is vital as it signifies that the cushions meet specific medical necessity criteria and are eligible for reimbursement under Medicare, significantly improving access and affordability for eligible patients. This strategic inclusion underscores Kalogon’s commitment to making advanced rehabilitation technology accessible to those who need it most. All Verro cushions are proudly manufactured in-house at Kalogon’s state-of-the-art facility in Melbourne, Florida, ensuring stringent quality control and efficient production.

The company emphasizes that the Verro line is specifically engineered for wheelchair users whose complex body shapes and postural deformities necessitate a level of precision that cannot be achieved with standard or even semi-custom cushions. Conditions such as severe scoliosis, kyphosis, pelvic rotation, or significant muscle tone imbalances often lead to discomfort, instability, and a heightened risk of pressure injuries when not adequately supported. Verro aims to provide a tailored interface that conforms intimately to these unique anatomies, offering targeted support and relief where it is most needed.

Chronology: From Clinical Need to Innovative Solution

Kalogon’s journey to the Verro line is rooted in a consistent commitment to addressing unmet needs in the complex rehab technology sector. Founded with a vision to enhance the lives of individuals with mobility challenges, Kalogon has previously made a name for itself with smart seating solutions like the Orbiter Med, which integrates advanced sensor technology to monitor and manage pressure redistribution actively. This foundation of innovation and a user-centric approach laid the groundwork for the development of Verro.

The genesis of Verro specifically emerged from direct feedback from clinicians and seating specialists. Tim Balz, CEO and founder of Kalogon, recounted the recurring concern: "We kept hearing from clinicians that their most complex patients were falling through the cracks." This critical insight highlighted a persistent gap in the market – while numerous custom seating solutions existed, none offered the granular, localized control necessary to truly accommodate the most intricate postural challenges. Traditional custom cushions, often involving manual carving or molding of foam, presented limitations in achieving the precise, variable firmness required to simultaneously support severe deformities and protect vulnerable pressure points.

Responding to this identified clinical imperative, Kalogon embarked on an ambitious research and development phase. The team explored emerging manufacturing technologies, ultimately focusing on the transformative potential of 3D printing. The decision to pursue a patent-pending variable-density lattice technology was a direct result of seeking a solution that could overcome the limitations of conventional materials. This process involved extensive material science research, iterative design, and rigorous testing to perfect the elastomer composition and the lattice structures that could deliver both firm support and soft pressure diffusion within the same contiguous material. The development of Verro Foam, with its dual-density approach, followed as a complementary offering, acknowledging the diverse preferences and clinical methodologies within the seating community.

The official announcement of Verro marks the culmination of these efforts, bringing to market a product line that directly addresses a long-standing challenge. While the exact date of the initial concept or R&D commencement is not specified, the launch in [e.g., July 2026] signifies the point at which Kalogon deemed the technology mature and ready for broad clinical application. This launch is not merely an incremental update but represents a strategic expansion for Kalogon, solidifying its position as a forward-thinking leader in rehabilitation technology and setting a new benchmark for personalized seating solutions.

Supporting Data: The Science Behind Precision Seating

The need for highly customized wheelchair cushions is underscored by the complex biomechanical challenges faced by a significant population of wheelchair users. According to various rehabilitation studies, a substantial percentage of individuals relying on wheelchairs for mobility suffer from postural asymmetries, musculoskeletal deformities, or neurological conditions that necessitate specialized seating interventions. Conditions such as cerebral palsy, spinal cord injury, multiple sclerosis, muscular dystrophy, stroke, and acquired brain injury often result in unique and evolving postural needs that standard seating cannot adequately support.

Challenges with Traditional Custom Cushions:
Traditional custom seating typically involves a labor-intensive process of creating molds or carving foam. While offering more customization than off-the-shelf options, these methods often fall short in several critical areas:

1. Limited Precision in Density Variation: Achieving precise, localized variations in firmness across the cushion surface is difficult with foam or gel. This means that areas requiring firm support might inadvertently apply too much pressure, while areas needing pressure relief might lack sufficient stability.
2. Long Lead Times: The manual nature of traditional custom cushion fabrication often leads to extended waiting periods, sometimes weeks or even months, which can delay patient rehabilitation and increase the risk of secondary complications.
3. Compromised Breathability: Many custom cushions, especially those made from dense foam or gel, can trap heat and moisture, increasing the risk of skin maceration and pressure injuries.
4. Cost and Adaptability: The initial high cost of traditional custom solutions, combined with their limited adaptability to changes in a user’s posture or condition over time, presents ongoing challenges.

Benefits of 3D Printing in Medical Devices:
The advent of 3D printing has revolutionized various sectors, and its application in medical devices, particularly in orthotics and prosthetics, has demonstrated profound advantages:

• Unparalleled Customization: 3D printing allows for the creation of geometries that are impossible with traditional manufacturing, enabling perfect, patient-specific fit.
• Material Versatility: A wide range of materials, from rigid plastics to flexible elastomers, can be printed, each with specific mechanical properties.
• Precision and Repeatability: Digital design ensures exact replication and consistent quality, crucial for medical applications.
• Design Iteration and Speed: Rapid prototyping allows for quick design modifications and faster production cycles.

Technical Details of Verro:

Verro Lattice:
Kalogon’s patent-pending variable-density lattice technology is the cornerstone of the Verro Lattice model. This technology leverages the power of additive manufacturing to create a cushion from a high-performance elastomer. The "variable-density" aspect refers to the ability to design the internal lattice structure with varying cell sizes, wall thicknesses, and geometries.

• Mechanism: By manipulating these parameters, Kalogon can precisely control the material’s response to load. For instance, in areas requiring more support (e.g., around the pelvis to correct obliquity), the lattice might feature smaller cells and thicker walls, resulting in a firmer feel. Conversely, in high-pressure areas (e.g., over ischial tuberosities), the lattice can be designed with larger cells and thinner walls, providing a softer, more compliant surface for pressure diffusion.
• Material: The use of an elastomer ensures both flexibility and durability, allowing the cushion to conform to the body while maintaining its structural integrity over time. Elastomers are also known for their resilience, ensuring the cushion retains its properties even after prolonged use.
• Breathability and Temperature Regulation: The open, interconnected structure of the lattice naturally promotes airflow, which helps dissipate heat and moisture away from the skin. This significantly reduces the risk of skin breakdown caused by prolonged exposure to heat and humidity, a critical concern for wheelchair users.

Verro Foam:
The Verro Foam model, while utilizing more conventional materials, employs a strategic dual-density approach to offer a balanced solution:

• Dense Foam Base: Provides foundational stability and prevents bottoming out, ensuring consistent support for the user’s posture.
• Soft Foam Topper: Offers immediate comfort and conforms gently to the body, distributing pressure more evenly across the contact surface.
• Adaptability: This construction is particularly appealing to seating specialists who require the ability to make minor in-field modifications to the cushion, such as carving out specific areas for additional pressure relief, an option not readily available with the lattice structure. It also offers a familiar feel for users accustomed to foam-based cushions.

Ordering Process and Efficiency:
Kalogon streamlines the ordering process through its "Launch Pad" interactive real-time configurator, offering two distinct pathways:

1. Scan & Order: This method utilizes a precise 3D scan of the user’s body, typically captured by a clinician using specialized equipment. The 3D data provides an exact anatomical map, allowing Kalogon to design a cushion that perfectly matches the user’s contours and support needs, leveraging the full capabilities of the variable-density lattice.
2. Build & Order: Clinicians can also input specific measurements, postural corrections, and desired cushion parameters directly into the configurator. This method allows for a high degree of customization based on clinical assessment and experience, particularly useful for Verro Foam orders or when 3D scanning is not readily available.

Crucially, Kalogon pledges to ship all Verro cushions within 14 days of receiving an order. This rapid turnaround time is a significant differentiator in the CRT market, where custom cushion lead times can often extend to several weeks or even months. Expedited delivery means patients receive their essential equipment faster, reducing waiting periods and allowing for quicker intervention in managing complex seating issues. The in-house manufacturing in Melbourne, FL, plays a vital role in achieving this efficiency, granting Kalogon complete control over the production timeline and quality.

Official Responses: Expert Validation and Visionary Leadership

The launch of Verro is met with enthusiastic endorsement from Kalogon’s leadership and respected figures in the rehabilitation community, underscoring the product’s potential impact.

Tim Balz, CEO and Founder of Kalogon, articulated the core philosophy driving Verro’s development: "We kept hearing from clinicians that their most complex patients were falling through the cracks, so we developed a technology that lets us 3D print the cushion with precise, localized control over where the body gets support and where it gets relief." Balz’s statement highlights not only the responsiveness of Kalogon to clinical needs but also the strategic deployment of advanced technology to solve persistent problems. He further emphasized the transformative nature of the 3D-printed lattice: "With our variable-density lattice, we can create subtle variations across the surface and sides of the cushion that simply aren’t possible with traditional materials. The customization options are hyper-personalized to provide the best comfort, support and fit for every customer." This vision of "hyper-personalization" is central to Kalogon’s mission, aiming to move beyond a one-size-fits-many approach to truly individualize assistive devices. Balz’s insight points to a paradigm shift, where manufacturing constraints no longer dictate design possibilities, but rather, clinical needs drive technological innovation.

Providing an invaluable clinical perspective, Kelly Waugh, MA, PT, ATP, and an advisor to Kalogon, lauded the flexibility and expanded capabilities that Verro brings to seating specialists. As an Assistive Technology Professional and Physical Therapist, Waugh’s expertise is highly regarded in the field. She commented, "Every client is different, and seating specialists need options that reflect that. Verro gives us more ways to match the right solution to each unique person based on their postural support needs, personal preferences and desire for in-field modification." Her statement underscores the critical importance of having a diverse toolkit for clinicians, acknowledging that no single solution fits all. Waugh further noted, "That flexibility will allow Kalogon to serve a much wider population of people with complex seating needs than before." This expert validation confirms that Verro is not just a technological marvel but a practical, clinically relevant solution that will empower seating specialists to deliver better outcomes for a broader range of patients. Her emphasis on "in-field modification" also highlights the thoughtful inclusion of the Verro Foam model, which caters to specific clinical practices and user preferences for adaptability.

These official responses collectively paint a picture of a company driven by a clear understanding of market needs, backed by innovative engineering, and validated by clinical experts. The synergy between technological prowess and practical application is what positions Verro as a significant advancement in complex rehab seating.

Implications: A Transformative Impact on Users, Clinicians, and the CRT Market

The introduction of Kalogon’s Verro custom wheelchair cushion line carries far-reaching implications, poised to significantly impact the lives of wheelchair users, the practice of seating specialists, and the broader complex rehab technology (CRT) market.

Impact on Users:
For individuals with complex seating needs, Verro promises a profound improvement in several key areas:

• Enhanced Comfort and Stability: The hyper-personalized fit and precise distribution of firmness will lead to significantly greater comfort, reducing discomfort and fatigue associated with prolonged sitting. Improved stability means better balance and reduced effort to maintain posture.
• Reduced Risk of Pressure Injuries: By diffusing pressure precisely in vulnerable areas and maintaining optimal posture, Verro can dramatically lower the incidence and severity of pressure sores (decubitus ulcers), a debilitating and costly complication for many wheelchair users.
• Improved Postural Alignment and Function: Correcting postural deformities like windswept posture or pelvic obliquity can improve respiratory function, digestion, and reach, leading to greater functional independence in daily activities.
• Greater Quality of Life: Beyond physical benefits, improved comfort, reduced pain, and enhanced function contribute directly to a better overall quality of life, allowing users to participate more fully in social, educational, and vocational pursuits.
• Faster Access to Care: The promised 14-day turnaround time means individuals will receive their essential custom seating much faster, preventing delays in rehabilitation and minimizing the period of discomfort or risk associated with inadequate seating.

Impact on Clinicians and Seating Specialists:
Verro provides seating specialists with powerful new tools to address their most challenging cases:

• Expanded Treatment Options: Clinicians now have access to a truly novel technology (variable-density 3D-printed lattice) alongside a versatile foam option, allowing for a more precise match between the client’s needs and the available solution.
• Increased Confidence in Prescriptions: The ability to achieve such precise, localized control over support and pressure relief instills greater confidence in the prescribed solution’s effectiveness and its potential to prevent secondary complications.
• Streamlined Workflow: The efficient ordering process via "Launch Pad" and the rapid manufacturing time will simplify clinical workflow, reducing administrative burdens and allowing clinicians to focus more on patient care.
• Data-Driven Customization: The "Scan & Order" method, utilizing 3D body scans, introduces a new level of data-driven precision to custom seating, enhancing objective assessment and outcome measurement.

Impact on the Complex Rehab Technology (CRT) Market:
Verro’s launch is poised to influence the CRT market in several ways:

• Setting a New Standard for Customization: Kalogon’s 3D-printed variable-density lattice technology establishes a new benchmark for precision and personalization in custom seating, likely prompting other manufacturers to explore similar advanced manufacturing techniques.
• Driving Innovation: The success of Verro could accelerate the adoption of additive manufacturing across the CRT sector, fostering a new wave of innovation in other assistive devices.
• Shifting Market Expectations: Users and clinicians may begin to expect higher levels of customization, faster delivery times, and more technologically advanced solutions, pushing the entire industry forward.
• Importance of Medicare Coding: The E2609 Medicare code is crucial for market penetration. Its inclusion ensures that these advanced solutions are not limited to a select few but are accessible to a wider population, reinforcing the importance of reimbursement for innovative technologies.
• Kalogon’s Strategic Position: This launch significantly strengthens Kalogon’s position as a leader in smart seating solutions. By expanding its product line beyond actively monitoring "smart" cushions to include passively adaptive custom cushions, Kalogon demonstrates its versatility and commitment to comprehensive seating solutions, catering to a broader range of clinical needs and preferences. This strategic move could solidify its market share and reputation as a holistic innovator in the rehabilitation space.

In essence, Verro is more than just a new product; it represents a significant step towards the future of personalized healthcare in rehabilitation. By harnessing the power of advanced manufacturing and a deep understanding of human biomechanics, Kalogon is not just selling cushions; it is selling the promise of improved health outcomes, greater independence, and a higher quality of life for those who rely on wheelchairs. This technological leap has the potential to reshape how complex seating needs are addressed, setting a new standard for precision, efficiency, and patient-centered care in the assistive technology landscape.